Drug resistant malaria on the Thai-Myanmar and Thai-Cambodian borders

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 32, Issue 1, 2001, Pages 41-49

  Wongsrichanalai, Chansuda ^a   Sirichaisinthop, Jeeraphat ^b   Karwacki, Jerome J ^a   Congpuong, Kanungnit ^c   Miller, R Scott ^a   Pang, Lorrin ^c   Thimasarn, Krongthong ^c  

^a ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^b Off of Vec Borne Dis Contr No 1   (Thailand)

^c MINISTRY OF PUBLIC HEALTH   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; ARTESUNATE; MEFLOQUINE; SESQUITERPENE;

ANIMAL; CAMBODIA; DRUG EFFECT; DRUG RESISTANCE; HUMAN; MALARIA FALCIPARUM; MYANMAR; PLASMODIUM FALCIPARUM; REVIEW; THAILAND;

ANIMALS; ANTIMALARIALS; ARTEMISININS; CAMBODIA; DRUG RESISTANCE; HUMANS; MALARIA, FALCIPARUM; MEFLOQUINE; MYANMAR; PLASMODIUM FALCIPARUM; SESQUITERPENES; THAILAND;

EID: 0035288592     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Basco LK, Le Bras J. In vitro activity of artemisinin derivatives against African isolates and clones of Plasmodium falciparum. Am J Trop Med Hyg 1993; 49: 301-7.
2. Boudreau EF, Webster HK, Pavanand K, Thosingha L. Type II mefloquine resistance in Thailand. Lancet 1982; ii: 1335.
3. Bustos MDG, Gay F, Diquet B. In vitro tests on Philippine isolates of Plasmodium falciparum falciparum against standard antimalarials and four qinghaosu derivatives. Bull WHO 1994; 72: 729-36.
4. Fontanet AL, Walker AM. Predictors and treatment failure in multiple drug-resistant falciparum malaria: results from a 42-day follow-up of 224 patients in eastern Thailand. Am J Trop Med Hyg 1993; 49: 463-72.
5. Hall AP. The treatment of malaria. Br Med J 1976; 1: 323-8.
6. Harinasuta T, Suntharasamai P, Viravan C. Chloroquine-resistant falciparum malaria in Thailand. Lancet 1965; 2: 657-60.
7. Harinasuta T, Viravan C, Reid HA. Sulphormethoxine in chloroquine-resistant falciparum malaria in Thailand. Lancet 1967; 1: 1117-9.
8. Harinasuta T, Bunnag D, Chongsuphajaisiddhi T, Laotavorn J. Efficacy of antimalarial drugs against falciparum malaria in Thailand. In: Laotavorn J, Harinasuta T, eds. Drug resistant malaria, Technical Report Series No. 1 of the Expert Committee on Drug Resistant Malaria, Bangkok. 1991: 40-65.
9. Karwacki JJ, Webster HK, Limsomwong N, Shanks GD. Two cases of mefloquine resistant malaria in Thailand. Trans R Soc Trop Med Hyg 1989; 83: 152-3.
10. Ketrangsee S, Vijaykadga S, Yamokgul P, Jatapadma S, Thimasarn K, Rooney W. Comparative trial on the response of Plasmodium falciparum of halofantrine and mefloquine in Trat Province, eastern Thailand. Southeast Asian J Trop Med Public Health 1992; 23: 55-8.
11. Kyle DE, Teja-Isavadharm P, Li Q, Leo K. Pharmacokinetics and pharmacodynamics of qinghaosu derivatives: how do they impact on the choice of drug and dosage regimens? Med Trop Mars 1998; 58 (suppl): 38-44.
12. Le Bras J. In vitro susceptibility of African Plasmodium falciparum isolates to dihydroartemisinin and the risk factors for resistance to qinghaosu. Med Trop 1998; 58 (3S): 18-21.
13. Malaria Division. Annual Report, BE 2533 and BE 2536. Department of Communicable Diseases Control, Ministry of Public Health, Nonthaburi, Thailand. 1991 and 1994.
14. Meshnick SR. Artemisinin antimalarials: mechanism of action and resistance. Med Trop Mars 1998; 58: (suppl) 13-17.
15. Nosten F, ter Kuile F, Chongsuphajaisiddhi T, et al. Mefloquine-resistant falciparum malaria on the Thai-Burmese border. Lancet 1991; 337: 1140-3.
16. Pinichpongse S, Doberstyn EB, Cullen JR, Yisunsri L, Thongsombun Y, Thimasarn K. An evaluation of five regimens for the outpatient therapy of falciparum malaria in Thailand. Bull WHO 1982; 60: 907-12.
17. Pinichpongse S, Suebsaeng L, Malikul S, Doberstyn EB, Rooney W. The operational introduction of mefloquine, a new anti-malarial drug by the Malaria Program of Thailand. Commun Dis J Thai 1987: 13: 411-24.
18. Pradines B, Rogier C, Fusai T, Tall A, Trape JF, Doury JC. In vitro activity of artemether against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial drugs. Am J Trop Med Hyg 1998; 58: 354-7.
19. Price RN, Nosten F, Luxemburger C, et al. Effects of artemisinin derivatives on malaria transmissibility. Lancet 1996; 347: 1654-8.
20. Rathod PK, McErlean T, Lee PC, Variations in frequencies of drug resistance in Plasmodium falciparum. Proc Natl Acad Sci USA 1997; 94: 9389-93.
21. Reed MB, Salba KJ, Caruana SR, Kirk K, Cowman AF. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum. Nature 2000; 403: 906-9.
22. Schapira A, Beales PF, Halloran ME. Malaria: living with drug resistance. Parasitol Today 1993; 9: 168-74.
23. Shanks GD. The rise and fall of mefloquine as an antimalarial drug in Southeast Asia. Milit Med 1994; 159: 275-81.
24. Suebsaeng L, Wernsdorfer WH, Rooney W. Sensitivity to quinine and mefloquine of Plasmodium falciparum in Thailand. Bull WHO 1986; 64: 759-65.
25. Thimasarn K, Pinichpongse S, Malikul S, Rooney W, Tansophalak S. Phase III double-blind Comparative study of Fansimef® and Lariam® for the curative treatment of Plasmodium falciparum malaria in Thailand. Southeast Asian J Trop Med Public Health 1990; 21: 404-11.
26. Thimasarn K. Chapter 7, Malaria situation at Bo Rai District. In: Laotavorn J, Harinasuta T, eds. Drug resistant malaria, Technical Report Series No. 1 of the Expert Committee on Drug Resistant Malaria, Bangkok. 1991: 124-30.
27. Thimasarn K, Sirichaisinthop J, Vijaykadga S, et al. In vivo study of the response of Plasmodium falciparum to standard mefloquine/sulfadoxine/pyrimethamine (MSP) treatment among gem miners returning from Cambodia. Southeast Asian J Trop Med Public Health 1995; 26: 204-12.
28. VBDC, Department of Health. Annual Report Vector Borne Diseases Control Project, 1997. Department of Health, Ministry of Health, Yangon. 1999.
29. Von Seidlein L, Milligan P, Pinder M, et al. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial. Lancet 2000; 355: 352-7.
30. Webster HK, Boudreau EF, Pavanand K, Yongvanitchit K, Pang LW. Antimalarial drug susceptibility testing of Plasmodium falciparum in Thailand using a microdilution radioisotope method. Am J Trop Med Hyg 1985; 34: 228-35.
31. Wernsdorfer WH. The development and spread of drug-resistant malaria. Parasitol Today 1991; 7: 297-303.
32. Wernsdorfer WH. Epidemiology of drug resistance in malaria. Acta Tropica 1994; 56; 143-56.
33. Wernsdorfer WH, Chongsuphajaisiddhi T, Salazar NP. A symposium on containment of mefloquine-resistant falciparum malaria in Southeast Asia with special reference to border malaria. Southeast Asian J Trop Med Public Health 1994; 25: 11-8.
34. White NJ. Drug resistance in malaria. Br Med Bull 1998; 54: 703-15.
35. Wongsrichanalai C, Webster HK, Wimonwattrawatee T, et al. Emergence of multi-drug resistant Plasmodium falciparum in Thailand: in vitro tracking. Am J Trop Med Hyg 1992; 47: 112-6.
36. Wongsrichanalai C, Wimonwattrawatee T, Sookto P, et al. In vitro sensitivity to artesunate of P. falciparum in Thailand. Bull WHO 1999; 77: 392-8.
37. World Health Organization. Monitoring systems. In: Practical chemotherapy of malaria. Report of a WHO Scientific Group, Geneva: WHO Tech Rep Ser 1990; 6: 94.